Bank stocks have also rebounded since the presidential election. Cramer noted that all of the signals were there for investors to buy the banks, starting when JPMorgan CEO Jamie Dimon purchased 500,000 shares in the open market for $26.6 million on Feb. 11.
With JPMorgan closing at $79 on Monday, those shares are worth nearly $40 million.
"Maybe Dimon was lucky. Maybe he's just good. Either way, he's obviously still optimistic about JPMorgan, or else he would have taken up Trump on his offer to be Treasury secretary," Cramer said.
After years of outperformance, the stock of CVS Health suffered a 10-point straight decline last week, leading Jim Cramer to wonder if it is a broken company or merely a broken stock.
"CVS has gone from a market darling to a total dog, as its once-vaunted pharmacy benefit manager business has become an albatross around its neck and the company loses share to its rivals," Cramer said.
Shares of CVS tripled from the summer of 2011 to the summer of 2015, but then fell into free-fall. They closed at $76 on Monday. The business includes both its 7,800 retail pharmacies, and its pharmacy benefit manager (PBM) segments.
"Maybe they can turn things around, but for now, CVS remains in the penalty box until we see them take concrete steps to lessen their dependence on what was once the golden goose, now just a turkey headed for a carving," Cramer said.
In the Lightning Round, Cramer gave his take on a few caller favorite stocks:
American Tower: "There was a piece out today that Sprint might merge with T-Mobile and everybody decided to dump on American Tower. My thinking is when you get this kind of a move, you've got to wait until tomorrow mid-day because there are so many sellers out there."
AmSurg Corp: "This group is under pressure. Everything is so in flux in healthcare because of the new President that we just have to be on the sidelines. It's tough, because it looks so inexpensive. But sidelines is where we have to be."